Abacus Planning Group’s Pacific Biosciences PACB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$67.6K	Sell	51,238 -48,762	-49%	-$87.2K	0.01%	262
2025 Q4	$187K	Hold	100,000	–	–	0.02%	254
2025 Q3	$128K	Hold	100,000	–	–	0.02%	249
2025 Q2	$124K	Hold	100,000	–	–	0.02%	237
2025 Q1	$118K	Hold	100,000	–	–	0.02%	223
2024 Q4	$183K	Hold	100,000	–	–	0.03%	209
2024 Q3	$170K	Hold	100,000	–	–	0.03%	205
2024 Q2	$137K	Hold	100,000	–	–	0.03%	203
2024 Q1	$375K	Hold	100,000	–	–	0.07%	129
2023 Q4	$981K	Hold	100,000	–	–	0.21%	71
2023 Q3	$835K	Hold	100,000	–	–	0.2%	77
2023 Q2	$1.33M	Sell	100,000 -20,000	-17%	-$243K	0.32%	45
2023 Q1	$1.39M	Hold	120,000	–	–	0.36%	41
2022 Q4	$982K	Sell	120,000 -20,000	-14%	-$172K	0.27%	59
2022 Q3	$813K	Hold	140,000	–	–	0.25%	64
2022 Q2	$619K	Hold	140,000	–	–	0.18%	85
2022 Q1	$1.27M	Sell	140,000 -15,000	-10%	-$173K	0.34%	51
2021 Q4	$3.17M	Sell	155,000 -25,000	-14%	-$603K	0.85%	22
2021 Q3	$4.6M	Hold	180,000	–	–	1.46%	13
2021 Q2	$6.29M	Hold	180,000	–	–	1.92%	11
2021 Q1	$6M	Sell	180,000 -220,000	-55%	-$7.7M	1.92%	11
2020 Q4	$10.4M	Sell	400,000 -302,937	-43%	-$5.15M	3.2%	8
2020 Q3	$6.94M	Buy	+702,937	New	+$4.05M	2.53%	9